7 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 7 of 7 clinical reviews.
A clinical review of Aubrey de Grey's public relationship to longevity research compounds, senolytics, and the SENS framework, with peer-reviewed medical context from the HealthRX.com Medical Team.
How Aubrey de Grey's confirmed longevity research advocacy compares to other public figures discussing senolytics, rapamycin, NAD+ precursors, and anti-aging interventions, with clinical context from the HealthRX.com Medical Team.
A clinical look at Aubrey de Grey's public longevity advocacy, documented self-experimentation statements, and the science behind the SENS framework and senolytic compounds he champions.
Aubrey de Grey has spent decades advocating for longevity interventions. The HealthRX.com Medical Team examines what clinical science says about stopping or maintaining senolytic and longevity-research compounds.
Aubrey de Grey has spoken openly about longevity compounds and their side effects. The HealthRX.com Medical Team matches his public statements against peer-reviewed adverse-event data.
What Aubrey de Grey's public advocacy for SENS and senolytics teaches everyday patients about longevity medicine, realistic expectations, and the current clinical evidence.
The HealthRX.com Medical Team breaks down the longevity compounds Aubrey de Grey has publicly discussed, translating SENS research into real clinical context around senolytics, NAD+ precursors, and rapamycin.